These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10537783)

  • 1. Evidence-based medicine, utilities, and quality of life.
    Brown MM; Brown GC; Sharma S; Garrett S
    Curr Opin Ophthalmol; 1999 Jun; 10(3):221-6. PubMed ID: 10537783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.
    Brown GC; Brown MM; Lieske HB; Lieske PA; Brown KS; Lane SS
    Ophthalmology; 2011 Sep; 118(9):1834-43. PubMed ID: 21723614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
    Roe RH; Lass JH; Brown GC; Brown MM
    Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration.
    Brown GC; Brown MM; Brown HC; Kindermann S; Sharma S
    Ophthalmology; 2007 Jun; 114(6):1170-8. PubMed ID: 17320964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care economic analyses and value-based medicine.
    Brown MM; Brown GC; Sharma S; Landy J
    Surv Ophthalmol; 2003; 48(2):204-23. PubMed ID: 12686305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-utility analysis of cataract surgery in the second eye.
    Busbee BG; Brown MM; Brown GC; Sharma S
    Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems and solutions in calculating quality-adjusted life years (QALYs).
    Prieto L; Sacristán JA
    Health Qual Life Outcomes; 2003 Dec; 1():80. PubMed ID: 14687421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration.
    Brown MM; Brown GC; Brown HC; Peet J
    Ophthalmology; 2008 Jun; 115(6):1039-1045.e5. PubMed ID: 17976724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cost-Effectiveness of Ranibizumab for the Treatment of Diabetic Macular Edema.
    Brown GC; Brown MM; Turpcu A; Rajput Y
    Ophthalmology; 2015 Jul; 122(7):1416-25. PubMed ID: 25935787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cataract surgery cost utility revisited in 2012: a new economic paradigm.
    Brown GC; Brown MM; Menezes A; Busbee BG; Lieske HB; Lieske PA
    Ophthalmology; 2013 Dec; 120(12):2367-2376. PubMed ID: 24246824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.
    Gupta OP; Brown GC; Brown MM
    Am J Ophthalmol; 2008 May; 145(5):923-8. PubMed ID: 18329000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of obesity on cost per quality-adjusted life years gained following anterior cervical discectomy and fusion in elective degenerative pathology.
    Chotai S; Sielatycki JA; Parker SL; Sivaganesan A; Kay HL; Stonko DP; Wick JB; McGirt MJ; Devin CJ
    Spine J; 2016 Nov; 16(11):1342-1350. PubMed ID: 27394664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computerized model of cost-utility analysis for treatment of age-related macular degeneration.
    Fletcher EC; Lade RJ; Adewoyin T; Chong NV
    Ophthalmology; 2008 Dec; 115(12):2192-8. PubMed ID: 18930556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal Collagen Cross-Linking in the Management of Keratoconus in Canada: A Cost-Effectiveness Analysis.
    Leung VC; Pechlivanoglou P; Chew HF; Hatch W
    Ophthalmology; 2017 Aug; 124(8):1108-1119. PubMed ID: 28457614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of case-based training for primary care physicians in evidence-based medicine of patients with coronary heart disease.
    Groot-Jensen S; Kiessling A; Zethraeus N; Björnstedt-Bennermo M; Henriksson P
    Eur J Prev Cardiol; 2016 Mar; 23(4):420-7. PubMed ID: 25896863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-utility of photodynamic therapy in eyes with neovascular macular degeneration--a value-based reappraisal with 5-year data.
    Brown GC; Brown MM; Campanella J; Beauchamp GR
    Am J Ophthalmol; 2005 Oct; 140(4):679-87. PubMed ID: 16226519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental cost-effectiveness of initial cataract surgery.
    Busbee BG; Brown MM; Brown GC; Sharma S
    Ophthalmology; 2002 Mar; 109(3):606-12; discussion 612-3. PubMed ID: 11874769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value-based medicine: evidence-based medicine and beyond.
    Brown GC; Brown MM; Sharma S
    Ocul Immunol Inflamm; 2003 Sep; 11(3):157-70. PubMed ID: 14566642
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.